Simplex Trading’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-33,800
| Closed | -$3K | – | 9951 |
|
|
2024
Q2 | $3K | Sell |
33,800
-6,400
| -16% | -$95K | ﹤0.01% | 8204 |
|
|
2024
Q1 | $593K | Sell |
40,200
-5,700
| -12% | -$80.1K | ﹤0.01% | 3683 |
|
|
2023
Q4 | $615K | Sell |
45,900
-10,300
| -18% | -$130K | ﹤0.01% | 3479 |
|
|
2023
Q3 | $692K | Buy |
56,200
+40,200
| +251% | +$487K | ﹤0.01% | 3046 |
|
|
2023
Q2 | $196K | Sell |
16,000
-49,500
| -76% | -$619K | ﹤0.01% | 4315 |
|
|
2023
Q1 | $804K | Buy |
65,500
+30,900
| +89% | +$363K | ﹤0.01% | 2792 |
|
|
2022
Q4 | $396K | Buy |
34,600
+21,700
| +168% | +$179K | ﹤0.01% | 3423 |
|
|
2022
Q3 | $48K | Buy |
12,900
+7,000
| +119% | +$32.3K | ﹤0.01% | 6518 |
|
|
2022
Q2 | $35K | Sell |
5,900
-3,300
| -36% | -$18.6K | ﹤0.01% | 6969 |
|
|
2022
Q1 | $58K | Sell |
9,200
-6,300
| -41% | -$35.4K | ﹤0.01% | 6951 |
|
|
2021
Q4 | $60K | Buy |
15,500
+11,100
| +252% | +$48.2K | ﹤0.01% | 7025 |
|
|
2021
Q3 | $27K | Hold |
4,400
| – | – | ﹤0.01% | 8185 |
|
|
2021
Q2 | $28K | Buy |
4,400
+4,176
| +1,864% | +$27.6K | ﹤0.01% | 8303 |
|
|
2021
Q1 | $140K | Sell |
224
-510
| -69% | -$3.65K | ﹤0.01% | 5285 |
|
|
2020
Q4 | $505K | Sell |
734
-79
| -10% | -$390 | ﹤0.01% | 3410 |
|
|
2020
Q3 | $325K | Buy |
813
+701
| +626% | +$2.58K | ﹤0.01% | 3518 |
|
|
2020
Q2 | $37K | Buy |
112
+39
| +53% | +$133 | ﹤0.01% | 5766 |
|
|
2020
Q1 | $15K | Buy |
73
+39
| +115% | +$114 | ﹤0.01% | 6207 |
|
|
2019
Q4 | $10K | Buy |
+34
| New | +$136 | ﹤0.01% | 6412 |
|
|
2018
Q4 | – | Sell |
-32
| Closed | -$13K | – | 8478 |
|
|
2018
Q3 | $13K | Sell |
32
-325
| -91% | -$1.37K | ﹤0.01% | 6291 |
|
|
2018
Q2 | $137K | Buy |
+357
| New | +$2.37K | ﹤0.01% | 3932 |
|
|
2017
Q2 | – | Sell |
-60
| Closed | -$6K | – | 7337 |
|
|
2017
Q1 | $6K | Buy |
60
+53
| +757% | +$1.33K | ﹤0.01% | 4522 |
|
|
2016
Q4 | $1K | Sell |
7
-47
| -87% | -$2K | ﹤0.01% | 5688 |
|
|
2016
Q3 | $63K | Buy |
54
+19
| +54% | +$789 | ﹤0.01% | 1917 |
|
|
2016
Q2 | $2K | Buy |
35
+2
| +6% | +$109 | ﹤0.01% | 5126 |
|
|
2016
Q1 | $13K | Buy |
+33
| New | +$1.72K | ﹤0.01% | 3257 |
|
|
2015
Q4 | – | Sell |
-42
| Closed | -$18K | – | 6646 |
|
|
2015
Q3 | $18K | Buy |
+42
| New | +$3.43K | ﹤0.01% | 2939 |
|
|
2015
Q2 | – | Sell |
-8
| Closed | -$33K | – | 6284 |
|
|
2015
Q1 | $33K | Sell |
8
-1
| -11% | -$85 | ﹤0.01% | 1893 |
|
|
2014
Q4 | $12K | Buy |
+9
| New | +$656 | ﹤0.01% | 2492 |
|
Simplex Trading's MACK Position: Q4 2022 in Review
Simplex Trading sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q4 2022, closing a stake of 8,692 shares — an estimated $71.6K sold.
Simplex Trading first reported a position in MACK in Q2 2015 and held it in 19 quarters. The position peaked at $470K in Q3 2016. 47 funds tracked by Wall St. Rank hold MACK as of Q4 2022.
- Simplex Trading reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
- Simplex Trading sold 8,692 Merrimack Pharmaceuticals, Inc. shares in Q4 2022, an estimated $71.6K.
- Simplex Trading first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2015 and held it in 19 quarters.
- Simplex Trading's Merrimack Pharmaceuticals, Inc. position peaked at $470K in Q3 2016.
- 47 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q4 2022.
Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.